Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2)
- 5 January 2013
- journal article
- Published by Elsevier BV in Journal of Immunological Methods
- Vol. 389 (1-2), 52-60
- https://doi.org/10.1016/j.jim.2012.12.010
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibodyJournal of Immunological Methods, 2012
- Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin‐(1–7) or an angiotensin II receptor antagonistThe Journal of Pathology, 2011
- Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon BetaArchives of Neurology, 2010
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatmentNature Biotechnology, 2008
- A novel method for detecting neutralizing antibodies against therapeutic proteins by measuring gene expressionJournal of Immunological Methods, 2006
- Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsJournal of Immunological Methods, 2004
- A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patientsEuropean Heart Journal, 2002